Exosome Diagnostic & Therapeutic Market 2027 By Product, Application, End User and Geography | The Insight Partners

Exosome Diagnostic & Therapeutic Market to 2027 - Global Analysis and Forecasts by Product (Instrument, Reagents, Software); Application (Diagnostic Application, Therapeutic Application); End User (Cancer Institutes, Hospitals, Diagnostic Centers and Other End Users) and Geography

Report Code: TIPRE00005514 | No. of Pages: 150 | Category: Biotechnology | Status: Upcoming
MARKET INTRODUCTION
The extracellular vescicles of endosomal origin are called exosome. These are miRNA and mRNA bodies which are secreted by body fluid cells of blood, saliva and amniotic fluid. Exosome have properties such as, stability and regeneration. These properties have made it possible to use them for therapeutic purposes of gene and drug delivery.

MARKET DYNAMICS
The exosome diagnostic & therapeutic market is anticipated to grow in the forecast period owing to increasing R&D work in biotechnology and pharmaceutical sector and in oncology. Moreover, the use of exosome as biomarker in diagnostic applications and growing prevalence of cancer expected to offer growth opportunities in the market during the forecast period.

MARKET SCOPE
The "Global Exosome Diagnostic & Therapeutic Market Analysis to 2027" is a specialized and in-depth study of the biotechnology industry with a special focus on the global market trend analysis. The report aims to provide an overview of exosome diagnostic & therapeutic market with detailed market segmentation by product, application, end user and geography. The global exosome diagnostic & therapeutic market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading exosome diagnostic & therapeutic market players and offers key trends and opportunities in the market.

MARKET SEGMENTATION
The global exosome diagnostic & therapeutic market market is segmented on the basis of product, application and end user. On the basis of product, the market is calassified as instrument, software and reagent. Based on application, the market is bifurcated into diagnostic application and therapeutic application. Based on therapeutic area, the exosome diagnostic & therapeutic market is divided into cancer institutes, hospitals, diagnostic centers and other end users.
REGIONAL FRAMEWORK
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global exosome diagnostic & therapeutic market based on various segments. It also provides market size and forecast estimates from year 2017 to 2027 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The exosome diagnostic & therapeutic market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting exosome diagnostic & therapeutic market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the exosome diagnostic & therapeutic market in these regions.

MARKET PLAYERS
The reports cover key developments in the exosome diagnostic & therapeutic market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the market were acquisitions and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market payers from exosome diagnostic & therapeutic market are anticipated to lucrative growth opportunities in the future with the rising demand for exosome diagnostic & therapeutic market in the global market. Below mentioned is the list of few companies engaged in the exosome diagnostic & therapeutic market.

The report also includes the profiles of key exosome diagnostic & therapeutic market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.
  • 101 Bio
  • Therapeutic Solutions International, Inc.
  • ReNeuron Group plc
  • Thermo Fisher Scientific Inc.
  • Cell Guidance Systems LLC
  • BioRegenerative Sciences
  • Evomic Science LLC.
  • Norgen Biotek Corp.
  • Exosome Diagnostics
  • Miltenyi Biotec
The Insight Partner's dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.

TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Exosome Diagnostic & Therapeutic Market - By Product
1.3.2 Exosome Diagnostic & Therapeutic Market - By Application
1.3.3 Exosome Diagnostic & Therapeutic Market - By End User
1.3.4 Exosome Diagnostic & Therapeutic Market - By Region
1.3.4.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. EXOSOME DIAGNOSTIC & THERAPEUTIC MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. EXOSOME DIAGNOSTIC & THERAPEUTIC MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. EXOSOME DIAGNOSTIC & THERAPEUTIC MARKET - GLOBAL MARKET ANALYSIS
6.1. EXOSOME DIAGNOSTIC & THERAPEUTIC - GLOBAL MARKET OVERVIEW
6.2. EXOSOME DIAGNOSTIC & THERAPEUTIC - GLOBAL MARKET AND FORECAST TO 2027
6.3. MARKET POSITIONING/MARKET SHARE

7. EXOSOME DIAGNOSTIC & THERAPEUTIC MARKET - REVENUE AND FORECASTS TO 2027 - PRODUCT
7.1. OVERVIEW
7.2. PRODUCT MARKET FORECASTS AND ANALYSIS
7.3. INSTRUMENT
7.3.1. Overview
7.3.2. Instrument Market Forecast and Analysis
7.4. REAGENTS
7.4.1. Overview
7.4.2. Reagents Market Forecast and Analysis
7.5. SOFTWARE
7.5.1. Overview
7.5.2. Software Market Forecast and Analysis
8. EXOSOME DIAGNOSTIC & THERAPEUTIC MARKET - REVENUE AND FORECASTS TO 2027 - APPLICATION
8.1. OVERVIEW
8.2. APPLICATION MARKET FORECASTS AND ANALYSIS
8.3. DIAGNOSTIC APPLICATION
8.3.1. Overview
8.3.2. Diagnostic Application Market Forecast and Analysis
8.4. THERAPEUTIC APPLICATION
8.4.1. Overview
8.4.2. Therapeutic Application Market Forecast and Analysis

9. EXOSOME DIAGNOSTIC & THERAPEUTIC MARKET - REVENUE AND FORECASTS TO 2027 - END USER
9.1. OVERVIEW
9.2. END USER MARKET FORECASTS AND ANALYSIS
9.3. CANCER INSTITUTES
9.3.1. Overview
9.3.2. Cancer Institutes Market Forecast and Analysis
9.4. HOSPITALS
9.4.1. Overview
9.4.2. Hospitals Market Forecast and Analysis

9.5. DIAGNOSTIC CENTERS
9.5.1. Overview
9.5.2. Diagnostic Centers Market Forecast and Analysis
9.6. OTHER END USERS
9.6.1. Overview
9.6.2. Other End Users Market Forecast and Analysis
10. EXOSOME DIAGNOSTIC & THERAPEUTIC MARKET REVENUE AND FORECASTS TO 2027 - GEOGRAPHICAL ANALYSIS
10.1. NORTH AMERICA
10.1.1 North America Exosome Diagnostic & Therapeutic Market Overview
10.1.2 North America Exosome Diagnostic & Therapeutic Market Forecasts and Analysis
10.1.3 North America Exosome Diagnostic & Therapeutic Market Forecasts and Analysis - By Product
10.1.4 North America Exosome Diagnostic & Therapeutic Market Forecasts and Analysis - By Application
10.1.5 North America Exosome Diagnostic & Therapeutic Market Forecasts and Analysis - By End User
10.1.6 North America Exosome Diagnostic & Therapeutic Market Forecasts and Analysis - By Countries
10.1.6.1 United States Exosome Diagnostic & Therapeutic Market
10.1.6.1.1 United States Exosome Diagnostic & Therapeutic Market by Product
10.1.6.1.2 United States Exosome Diagnostic & Therapeutic Market by Application
10.1.6.1.3 United States Exosome Diagnostic & Therapeutic Market by End User
10.1.6.2 Canada Exosome Diagnostic & Therapeutic Market
10.1.6.2.1 Canada Exosome Diagnostic & Therapeutic Market by Product
10.1.6.2.2 Canada Exosome Diagnostic & Therapeutic Market by Application
10.1.6.2.3 Canada Exosome Diagnostic & Therapeutic Market by End User
10.1.6.3 Mexico Exosome Diagnostic & Therapeutic Market
10.1.6.3.1 Mexico Exosome Diagnostic & Therapeutic Market by Product
10.1.6.3.2 Mexico Exosome Diagnostic & Therapeutic Market by Application
10.1.6.3.3 Mexico Exosome Diagnostic & Therapeutic Market by End User
10.2. EUROPE
10.2.1 Europe Exosome Diagnostic & Therapeutic Market Overview
10.2.2 Europe Exosome Diagnostic & Therapeutic Market Forecasts and Analysis
10.2.3 Europe Exosome Diagnostic & Therapeutic Market Forecasts and Analysis - By Product
10.2.4 Europe Exosome Diagnostic & Therapeutic Market Forecasts and Analysis - By Application
10.2.5 Europe Exosome Diagnostic & Therapeutic Market Forecasts and Analysis - By End User
10.2.6 Europe Exosome Diagnostic & Therapeutic Market Forecasts and Analysis - By Countries
10.2.6.1 Germany Exosome Diagnostic & Therapeutic Market
10.2.6.1.1 Germany Exosome Diagnostic & Therapeutic Market by Product
10.2.6.1.2 Germany Exosome Diagnostic & Therapeutic Market by Application
10.2.6.1.3 Germany Exosome Diagnostic & Therapeutic Market by End User
10.2.6.2 France Exosome Diagnostic & Therapeutic Market
10.2.6.2.1 France Exosome Diagnostic & Therapeutic Market by Product
10.2.6.2.2 France Exosome Diagnostic & Therapeutic Market by Application
10.2.6.2.3 France Exosome Diagnostic & Therapeutic Market by End User
10.2.6.3 Italy Exosome Diagnostic & Therapeutic Market
10.2.6.3.1 Italy Exosome Diagnostic & Therapeutic Market by Product
10.2.6.3.2 Italy Exosome Diagnostic & Therapeutic Market by Application
10.2.6.3.3 Italy Exosome Diagnostic & Therapeutic Market by End User
10.2.6.4 Spain Exosome Diagnostic & Therapeutic Market
10.2.6.4.1 Spain Exosome Diagnostic & Therapeutic Market by Product
10.2.6.4.2 Spain Exosome Diagnostic & Therapeutic Market by Application
10.2.6.4.3 Spain Exosome Diagnostic & Therapeutic Market by End User
10.2.6.5 United Kingdom Exosome Diagnostic & Therapeutic Market
10.2.6.5.1 United Kingdom Exosome Diagnostic & Therapeutic Market by Product
10.2.6.5.2 United Kingdom Exosome Diagnostic & Therapeutic Market by Application
10.2.6.5.3 United Kingdom Exosome Diagnostic & Therapeutic Market by End User
10.3. ASIA-PACIFIC
10.3.1 Asia-Pacific Exosome Diagnostic & Therapeutic Market Overview
10.3.2 Asia-Pacific Exosome Diagnostic & Therapeutic Market Forecasts and Analysis
10.3.3 Asia-Pacific Exosome Diagnostic & Therapeutic Market Forecasts and Analysis - By Product
10.3.4 Asia-Pacific Exosome Diagnostic & Therapeutic Market Forecasts and Analysis - By Application
10.3.5 Asia-Pacific Exosome Diagnostic & Therapeutic Market Forecasts and Analysis - By End User
10.3.6 Asia-Pacific Exosome Diagnostic & Therapeutic Market Forecasts and Analysis - By Countries
10.3.6.1 Australia Exosome Diagnostic & Therapeutic Market
10.3.6.1.1 Australia Exosome Diagnostic & Therapeutic Market by Product
10.3.6.1.2 Australia Exosome Diagnostic & Therapeutic Market by Application
10.3.6.1.3 Australia Exosome Diagnostic & Therapeutic Market by End User
10.3.6.2 China Exosome Diagnostic & Therapeutic Market
10.3.6.2.1 China Exosome Diagnostic & Therapeutic Market by Product
10.3.6.2.2 China Exosome Diagnostic & Therapeutic Market by Application
10.3.6.2.3 China Exosome Diagnostic & Therapeutic Market by End User
10.3.6.3 India Exosome Diagnostic & Therapeutic Market
10.3.6.3.1 India Exosome Diagnostic & Therapeutic Market by Product
10.3.6.3.2 India Exosome Diagnostic & Therapeutic Market by Application
10.3.6.3.3 India Exosome Diagnostic & Therapeutic Market by End User
10.3.6.4 Japan Exosome Diagnostic & Therapeutic Market
10.3.6.4.1 Japan Exosome Diagnostic & Therapeutic Market by Product
10.3.6.4.2 Japan Exosome Diagnostic & Therapeutic Market by Application
10.3.6.4.3 Japan Exosome Diagnostic & Therapeutic Market by End User
10.3.6.5 South Korea Exosome Diagnostic & Therapeutic Market
10.3.6.5.1 South Korea Exosome Diagnostic & Therapeutic Market by Product
10.3.6.5.2 South Korea Exosome Diagnostic & Therapeutic Market by Application
10.3.6.5.3 South Korea Exosome Diagnostic & Therapeutic Market by End User
10.4. MIDDLE EAST AND AFRICA
10.4.1 Middle East and Africa Exosome Diagnostic & Therapeutic Market Overview
10.4.2 Middle East and Africa Exosome Diagnostic & Therapeutic Market Forecasts and Analysis
10.4.3 Middle East and Africa Exosome Diagnostic & Therapeutic Market Forecasts and Analysis - By Product
10.4.4 Middle East and Africa Exosome Diagnostic & Therapeutic Market Forecasts and Analysis - By Application
10.4.5 Middle East and Africa Exosome Diagnostic & Therapeutic Market Forecasts and Analysis - By End User
10.4.6 Middle East and Africa Exosome Diagnostic & Therapeutic Market Forecasts and Analysis - By Countries
10.4.6.1 South Africa Exosome Diagnostic & Therapeutic Market
10.4.6.1.1 South Africa Exosome Diagnostic & Therapeutic Market by Product
10.4.6.1.2 South Africa Exosome Diagnostic & Therapeutic Market by Application
10.4.6.1.3 South Africa Exosome Diagnostic & Therapeutic Market by End User
10.4.6.2 Saudi Arabia Exosome Diagnostic & Therapeutic Market
10.4.6.2.1 Saudi Arabia Exosome Diagnostic & Therapeutic Market by Product
10.4.6.2.2 Saudi Arabia Exosome Diagnostic & Therapeutic Market by Application
10.4.6.2.3 Saudi Arabia Exosome Diagnostic & Therapeutic Market by End User
10.4.6.3 U.A.E Exosome Diagnostic & Therapeutic Market
10.4.6.3.1 U.A.E Exosome Diagnostic & Therapeutic Market by Product
10.4.6.3.2 U.A.E Exosome Diagnostic & Therapeutic Market by Application
10.4.6.3.3 U.A.E Exosome Diagnostic & Therapeutic Market by End User
10.5. SOUTH AND CENTRAL AMERICA
10.5.1 South and Central America Exosome Diagnostic & Therapeutic Market Overview
10.5.2 South and Central America Exosome Diagnostic & Therapeutic Market Forecasts and Analysis
10.5.3 South and Central America Exosome Diagnostic & Therapeutic Market Forecasts and Analysis - By Product
10.5.4 South and Central America Exosome Diagnostic & Therapeutic Market Forecasts and Analysis - By Application
10.5.5 South and Central America Exosome Diagnostic & Therapeutic Market Forecasts and Analysis - By End User
10.5.6 South and Central America Exosome Diagnostic & Therapeutic Market Forecasts and Analysis - By Countries
10.5.6.1 Brazil Exosome Diagnostic & Therapeutic Market
10.5.6.1.1 Brazil Exosome Diagnostic & Therapeutic Market by Product
10.5.6.1.2 Brazil Exosome Diagnostic & Therapeutic Market by Application
10.5.6.1.3 Brazil Exosome Diagnostic & Therapeutic Market by End User
10.5.6.2 Argentina Exosome Diagnostic & Therapeutic Market
10.5.6.2.1 Argentina Exosome Diagnostic & Therapeutic Market by Product
10.5.6.2.2 Argentina Exosome Diagnostic & Therapeutic Market by Application
10.5.6.2.3 Argentina Exosome Diagnostic & Therapeutic Market by End User
11. INDUSTRY LANDSCAPE
11.1. MERGERS AND ACQUISITIONS
11.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
11.3. NEW APPLICATION LAUNCHES
11.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
12. EXOSOME DIAGNOSTIC & THERAPEUTIC MARKET, KEY COMPANY PROFILES
12.1. 101 BIO
12.1.1. Key Facts
12.1.2. Business Description
12.1.3. Applications and Services
12.1.4. Financial Overview
12.1.5. SWOT Analysis
12.1.6. Key Developments
12.2. THERAPEUTIC SOLUTIONS INTERNATIONAL, INC.
12.2.1. Key Facts
12.2.2. Business Description
12.2.3. Applications and Services
12.2.4. Financial Overview
12.2.5. SWOT Analysis
12.2.6. Key Developments
12.3. RENEURON GROUP PLC
12.3.1. Key Facts
12.3.2. Business Description
12.3.3. Applications and Services
12.3.4. Financial Overview
12.3.5. SWOT Analysis
12.3.6. Key Developments
12.4. THERMO FISHER SCIENTIFIC INC.
12.4.1. Key Facts
12.4.2. Business Description
12.4.3. Applications and Services
12.4.4. Financial Overview
12.4.5. SWOT Analysis
12.4.6. Key Developments
12.5. CELL GUIDANCE SYSTEMS LLC
12.5.1. Key Facts
12.5.2. Business Description
12.5.3. Applications and Services
12.5.4. Financial Overview
12.5.5. SWOT Analysis
12.5.6. Key Developments
12.6. BIOREGENERATIVE SCIENCES
12.6.1. Key Facts
12.6.2. Business Description
12.6.3. Applications and Services
12.6.4. Financial Overview
12.6.5. SWOT Analysis
12.6.6. Key Developments
12.7. EVOMIC SCIENCE LLC.
12.7.1. Key Facts
12.7.2. Business Description
12.7.3. Applications and Services
12.7.4. Financial Overview
12.7.5. SWOT Analysis
12.7.6. Key Developments
12.8. NORGEN BIOTEK CORP.
12.8.1. Key Facts
12.8.2. Business Description
12.8.3. Applications and Services
12.8.4. Financial Overview
12.8.5. SWOT Analysis
12.8.6. Key Developments
12.9. EXOSOME DIAGNOSTICS
12.9.1. Key Facts
12.9.2. Business Description
12.9.3. Applications and Services
12.9.4. Financial Overview
12.9.5. SWOT Analysis
12.9.6. Key Developments
12.10. MILTENYI BIOTEC
12.10.1. Key Facts
12.10.2. Business Description
12.10.3. Applications and Services
12.10.4. Financial Overview
12.10.5. SWOT Analysis
12.10.6. Key Developments
13. APPENDIX
13.1. ABOUT THE INSIGHT PARTNERS
13.2. GLOSSARY OF TERMS
The List of Companies

- 101 Bio
- Therapeutic Solutions International, Inc.
- ReNeuron Group plc
- Thermo Fisher Scientific Inc.
- Cell Guidance Systems LLC
- BioRegenerative Sciences
- Evomic Science LLC.
- Norgen Biotek Corp.
- Exosome Diagnostics
- Miltenyi Biotec